In this study, we demonstrate that recombinant human PrP E219K, expressed in E. coli, is a promising alternative substrate for rapidly amplifying and detecting all human sCJD subtypes as well as vCJD prions. Here, PRNP is linked to variant Creutzfeldt-Jakob disease.